The role of the CCL25/CCR9 axis in the development of neuropathy requires research; however, in 2022, it was shown that in the CSF of patients who developed postoperative neuropathic pain after breast cancer surgery, an enhanced level of CCL25 was observed [136]. Here, CCL25 is linked to neuropathy.